Filteren op Last updated date SelectNaVoorFrom - To Date Einddatum Deze week Deze maand Afgelopen week Afgelopen maand Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Laat dit veld leeg Filter Resultaten (3838) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Laat dit veld leeg Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 November 2019 (updated) 15 november 2019NewsHumanData on medicines EMA confirms Xeljanz to be used with caution in patients at high risk of blood clots 15 november 2019Press releaseHumanMedicinesPharmacovigilanceReferrals Measures to minimise risk of serious side effects of multiple sclerosis medicine Lemtrada 15 november 2019Press releaseHumanMedicinesPharmacovigilanceReferrals First vaccine to protect against Ebola 14 november 2019Press releaseHumanMedicines Regulators’ advice can make a difference for faster patient access to highly innovative therapies 12 november 2019NewsCorporate ‘Regulatory science to 2025’: live broadcast of post-consultation workshop 11 november 2019NewsCorporate Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 5-7 November 2019 8 november 2019Press releaseVeterinaryData on medicines Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28-31 October 2019 31 oktober 2019NewsHumanPharmacovigilanceQuality of medicinesReferrals EMA closed 1 November 2019 31 oktober 2019News Regulatory update - EMA encourages companies to submit type I variations for 2019 by end of November 2019 29 oktober 2019News 1 … 97 98 99 100 101 Page 101 of 384 102 103 104 105 … 384
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 November 2019 (updated) 15 november 2019NewsHumanData on medicines
EMA confirms Xeljanz to be used with caution in patients at high risk of blood clots 15 november 2019Press releaseHumanMedicinesPharmacovigilanceReferrals
Measures to minimise risk of serious side effects of multiple sclerosis medicine Lemtrada 15 november 2019Press releaseHumanMedicinesPharmacovigilanceReferrals
Regulators’ advice can make a difference for faster patient access to highly innovative therapies 12 november 2019NewsCorporate
‘Regulatory science to 2025’: live broadcast of post-consultation workshop 11 november 2019NewsCorporate
Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 5-7 November 2019 8 november 2019Press releaseVeterinaryData on medicines
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28-31 October 2019 31 oktober 2019NewsHumanPharmacovigilanceQuality of medicinesReferrals
Regulatory update - EMA encourages companies to submit type I variations for 2019 by end of November 2019 29 oktober 2019News